“Alternative Endpoints Based on Health Outcomes in Stimulant Users Trials”, in 77th Annual Meeting of the College on Problems of Drug Dependence (CPDD), Phoenix, AZ, 2015.
, “Achieving Cannabis Cessation – Evaluating N-Acetylcysteine Treatment (ACCENT): Design and Implementation of a Multi-Site, Randomized Controlled Study in the National Institute on Drug Abuse Clinical Trials Network”, Contemp Clin Trials, vol. 39, pp. 211-223, 2014.
, “Optimizing an Existing Data Collection System for Tablet Compatibility: Considerations and a Case Study”, in Society for Clinical Trials 35th Annual Meeting, Philadelphia, PA, 2014.
, “Clinical Trial Management: Monitoring Progress, Sites and Safety; New Paradigms for Efficiency”, in 5th Annual Clinical Research Management Workshop at the Yale Center for Clinical Investigation, New Haven, CT, 2012.
, “Estimating Death Rates In Substance Use Disorder”, in The Society for Clinical Trials 33rd Annual Meeting, Miami, FL, 2012.
, “How Electronic Health Records (EHRs) Can Support Comparative Effectiveness Research (CER)”, in Annual Comparative Effectiveness Research Key Function Committee Meeting, Rockville, MD, 2012.
, “Implementation of a Drug Management Utility in a Multi-Site, Randomized, Double-Blinded Study”, in Society for Clinical Trials Annual Meeting, Miami, FL, 2012.
,